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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A159were stored in formalin-ﬁxed parafﬁn-embedded sections (decalciﬁed
before embedding and sectioning) and analysed by conventional
staining methods and immunohistochemistry (IHC) assays. Chon-
drocytes from cartilage were isolated using an inverted microscope and
tissue was digested using trypsin and collagenase. Primary chon-
drocytes were grown to 80-90% conﬂuence. Proliferation assay was
performed by counting cells with using automated cell counter. For IHC
cells were seed onto coverslips. The following are the antibodies used in
this study: anti-osteoponin, anti-ﬁbronectin, anti-collagen type II, anti-
Cx43, anti-PCNA and Ki67. Scrape loading assay was used to examine
GJIC
Results: Analysis of cartilage sections staining with Safranin O/Fast
Green, Hematoxylin-eosin eosin and Toluidine blue did not show sig-
niﬁcant differences between different phenotypes. However the
K258stop/KO cartilagewas thinner thanwild type and Cx43/KO. Besides
cartilage from K258stop/KO showed higher rate of positive cells for
PCNA. IHC experiments revealed that K258stop/KO chondrocytes in
primary culture contain less levels of collagen type II. K258stop/
K258stop was found to have 1.5-fold increase in cell proliferation in
comparison with wild type or Cx43/KO. Scrape loading assays suggest
that the deletion of CTD slightly reduce GJIC.
Conclusions: We have used a genetically modiﬁed murine model to
directly characterize, for the ﬁrst time, the role of the CTD of Cx43 on
cartilage structure. Our results strongly support the notion that the CTD
of Cx43 plays an important role in chondrocyte phenotype. It is well
know that through its CTD, Cx43 serves as scaffolding proteins that
associates with structural and signaling molecules leading to regulation
of intracellular signaling, independently of channel activity. This study
illustrates that a complete isolation of Cx43 from its CTD may have a
negative impact on cartilage structure and chondrocyte functions
within the tissue.
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THE EFFECTS OF THREE DIFFERENT CLASSES OF ANTI-
INFLAMMATORY AGENTS ON IN VITRO HUMAN OSTEOARTHRITIC
CHONDROCYTES EXPOSED TO IL-1b
S. Cheleschi y, G. Valacchi z, N.A. Pascarelli y, A. Di Capua x,
G. Belmonte z, A. Giordani x, M. Galeazzi y, A. Fioravanti y, M. Anzini x,
C. Sticozzi z. yDept. of Med., Surgery and NeuroSci., Rheumatology Unit,
Univ. of Siena, Siena, Italy; zDept. of Life Sci. and Biotechnology, Univ. of
Ferrara, Ferrara, Italy; xDept. of Biotechnology, Chemistry and Pharmacy,
Univ. of Siena, Siena, Italy; kRottapharm e Biotech, Monza, Italy
Purpose: VA694, a promising cyclooxigenase-2 (COX-2)-inhibiting
hybrid drug endowed with nitric oxide (NO) releasing properties (NO-
COXIB), showed COX-2-selective inhibitory effects, associated with
interesting anti-inﬂammatory and anti-nociceptive activities. For these
reason we performed an in vitro study to explore the effects of VA694
on cartilage metabolism, in comparison with Naproxcinod, a COX
inhibitor and NO donor (CINOD), and naproxen, a traditional non ster-
oidal-anti-inﬂammatory drug (NSAID) on human osteoarthritic chon-
drocyte cultures.
Methods: Human articular cartilage was obtained from femoral
heads of 5 patients (range 63-71 years) with Osteoarthritis (OA)
according to ACR criteria undergoing surgery for total hip pros-
theses. The chondrocytes were isolated from the articular cartilage
using sequential enzymatic digestion. The primary cultures so
obtained were seeded in 6-well plates until conﬂuence. Cells were
then incubated with two concentrations (1mg/ml and 10mg/ml) of
VA694, Naproxcinod and naproxen alone or in combination with
Interleukin (IL)-1b (5ng/ml) for 48h. In these experimental con-
ditions we evaluated cell viability by MMT assay, release of pros-
taglandin (PG)E2 through an ELISA kit, COX-2 and
metalloproteinases (MMP)-3, -9, -13 gene expression by real time
PCR, and activation of nuclear factor (NF)-kb by immunocy-
tochemistry. Data are expressed as the mean ± standard deviation
of triplicate values for each experiment. Statistical analysis wasperformed using an analysis of variance followed by Bonferroni
multiple comparison tests.
Results: VA694, Naproxcinod and naproxen tested alone at two differ-
ent concentrations studied didn’t signiﬁcantly modify cell viability,
while IL-1b-stimulated chondrocytes showed a signiﬁcant decrease in
cell viability (p<0.001). Both concentrations of all drugs tested restored,
in a signiﬁcant manner (p<0.01), cell proliferation.
No signiﬁcant modiﬁcation of PGE2 levels was observed in the
chondrocyte cultures treated with each of these drugs alone. The
presence of IL-1b determined a signiﬁcant increase (p<0.001, p<0.01,
p<0.01 respectively) in PGE2 levels and both concentrations of
VA694, Naproxcinod and naproxen, signiﬁcantly decreased the PGE2
levels in cells damaged with IL-1b (p<0.001, p<0.05, p<0.05
respectively).
We investigated the COX-2, MMP-3, -9, -13 gene expression by real time
PCR. VA694, Naproxcinod and naproxen tested at two different con-
centrations alone not signiﬁcantly modify the gene expression, while
IL-1b-stimulated chondrocytes induced a very signiﬁcant increase in
COX-2, MMP-3, -9, -13 gene expression (p<0.001). All the drugs tested
in our study signiﬁcantly inhibited COX-2 and MMP-3, -9, -13 gene
expression induced by IL-1b at both concentrations analysed (p<0.01,
p<0.05, p<0.05 respectively).
VA694, Naproxcinod and naproxen pre-treatment were able to inhibit
IL-1b-induced NFkB activation, as measured by its nuclear translocation
(p50 and p65 subunits). Naproxcinod and naproxen pre-treatment
didn’t affect cytoplasmic NFkB levels, while VA694 was able to decrease
the cytoplasmic levels of both subunits (Figure 1, Figure 2).
Conclusions: The results of the present study suggest that VA694,
Naproxcinod and naproxen exert anti-inﬂammatory and chon-
droprotective effects. These drugs in fact inhibit the production of PGE2,
COX-2 and MMP-3, -9, -13 gene expression, stimulated by IL-1b.
However, VA694 seems to have a more efﬁcient effect on NF-kB
inhibition.
Fig 1. Localization of NFkB, red (p50), green (p65) subunits by Immuno-
cytochemistry. Scalebar 50mm.
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A160Fig 2. Immunolabelling intensity forp50andp65 subunits, calculated using
the Image J software.
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MICRORNA-381 IN CHONDROGENESIS AND INTERLEUKIN-1-b
INDUCED CHONDROCYTE RESPONSES
Z. Zhang, C. Hou, F. Meng, Y. Kang, Z. Zhang, P. Sheng, W. Liao. First
Afﬁliated Hosp. of Sun Yat-sen Univ., Guangzhou, China
Purpose:Osteoarthritis is a debilitating joint condition characterized by
cartilage degradation. The pathways that regulate cartilage degradation
are still unclear. We previously identiﬁed miR-381 as a putative regu-
lator of chondrogenesis related genes. Therefore, the aim of this study
was to determine the role of miR-381 in chondrogenesis and cartilage
degeneration.
Methods: miR-381 expression was assessed in vitro by qRT-PCR in
response to IL-1b stimulation in primary human (PHC) and mouse
(PMC) chondrocytes, and the chondrocyte-like ATDC5 cell induced to
differentiate to chondrocytes with insulin, transferrin, and selenous
acid (ITS) þ premix. miR-381 expression was assessed in vivo in mouse
embryos and osteoarthritic cartilage by in situ hybridization. The effect
of miR-381 on chondrogenesis was assessed using a synthetic RNA
mimic or inhibitor. Luciferase assays were used to assess the role of
miR-381 in regulating NF-kB signaling. Upstream regulators were
probed using siRNA or overexpression plasmids for Sox9 and Runx2.
Results: miR-381 expression was elevated in chondrogenic and
hypertrophic ATDC5 cells. IL-1b-induced miR-381 expression in ATDC5
cells, PMCs, and PHCs. miR-381 was also expressed areas of cartilage
degradation absorption in mouse embryos and human osteoarthritic
cartilage. miR-381 expression was increased in ATDC5 cells over-
expressing Runx2 or Sox9. miR-381 suppressed the expression of
Col2a1 (collagen, type II, alpha 1) and enhanced the expression of
metalloproteinase-13 (MMP-13), but did not regulate NFKBIA and NKRF
activity.
Conclusions: miR-381 is highly expressed during chondrogenesis and
in arthritic cartilage. It is likely regulated by Sox9 and Runx2. miR-381
may contribute to absorption of the cartilage matrix by repressing
collagen II and inducing MMP-13.
